Acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine
C65H79F9IN13O8 — CID 159871281
Data last refreshed: (MolForge compound catalog, from PubChem)
About Acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine
Acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine (PubChem CID 159871281) has the molecular formula C65H79F9IN13O8 and a molecular weight of 1469.32 g/mol. Its IUPAC name is acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine.
Molecular Properties
| Compound Name | Acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine |
|---|---|
| PubChem CID | 159871281 |
| Molecular Formula | C65H79F9IN13O8 |
| Molecular Weight | 1469.32 g/mol |
| Exact Mass | 1468.51 |
| IUPAC Name | acetonitrile;deuterio(iodo)methane;1-methyl-3-(5-methyl-2-pyridinyl)-1-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]urea;N-methyl-3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propan-1-amine;N-methyl-N-[3-[[7-propyl-3-(trifluoromethyl)-1,2-benzoxazol-6-yl]oxy]propyl]imidazole-1-carboxamide;5-methylpyridin-2-amine |
| SMILES | CC#N.CCCc1c(OCCCN(C)C(=O)Nc2ccc(C)cn2)ccc2c(C(F)(F)F)noc12.CCCc1c(OCCCN(C)C(=O)n2ccnc2)ccc2c(C(F)(F)F)noc12.CCCc1c(OCCCNC)ccc2c(C(F)(F)F)noc12.Cc1ccc(N)nc1.[2H]CI |
| InChI | InChI=1S/C22H25F3N4O3.C19H21F3N4O3.C15H19F3N2O2.C6H8N2.C2H3N.CH3I/c1-4-6-15-17(9-8-16-19(15)32-28-20(16)22(23,24)25)31-12-5-11-29(3)21(30)27-18-10-7-14(2)13-26-18;1-3-5-13-15(7-6-14-16(13)29-24-17(14)19(20,21)22)28-11-4-9-25(2)18(27)26-10-8-23-12-26;1-3-5-10-12(21-9-4-8-19-2)7-6-11-13(10)22-20-14(11)15(16,17)18;1-5-2-3-6(7)8-4-5;1-2-3;1-2/h7-10,13H,4-6,11-12H2,1-3H3,(H,26,27,30);6-8,10,12H,3-5,9,11H2,1-2H3;6-7,19H,3-5,8-9H2,1-2H3;2-4H,1H3,(H2,7,8);1H3;1H3/i;;;;;1D |
| InChIKey | NSJKSSNTAWEWIV-WTMQMJMGSA-N |
| XLogP | 16.14 |
| TPSA | 263.87 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 96 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1469.32 |
| LogP ≤ 5 | 16.14 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159871281 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.